Clinical Trials at Cleveland Clinic May Give Hope to Those Diagnosed with Aggressive Brain Cancer

New Cleveland Clinic research shows for the first time that ibrutinib, an FDA-approved drug for lymphoma and leukemia, may also help treat the most common – and deadliest – type of brain tumor.

Read More  >